System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Samuel Katsuyuki Shinjo is an expert in Rheumatology at Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (Brazil). As of September 2026, ScienceLeadR ranks Samuel Katsuyuki Shinjo in the top 1% of experts worldwide for Myositis, Dermatomyositis and Vasculitis. Samuel Katsuyuki Shinjo has authored 473 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 3 of them ongoing. SLR score: 1,646 (community average: 125). How the SLR is computed.

LeadR Profile

Samuel Katsuyuki Shinjo Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Brazil
1 646 ScienceLeadR Reputation 1646

Unlock

Register Login
Network Map

Rheumatology

Subspecialties: Public Health - Internal Medicine - Neurology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1999 - 2026
Source: PubMed

Universidade de São Paulo

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 473

Citations

Citations: 4 743 1st author: 38 Last author: 241 Unique author: 4

Main journals

Rev Bras Reumatol 43
SBR 2021 Congresso Brasileiro de Reumatologia 32
Rheumatology (Oxford) 24
Adv Rheumatol 23
Clin Rheumatol 22

Best Journals

Circulation 1
Nat Med 1
Nat Rev Rheumatol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Mental- and physical-health comorbidity are strongly associated in idiopathic inflammatory myopathies: a multinational cross-sectional e-survey.
PMID 42667389 — muscular diseases, rheumatology, comorbidity, pain, neoplasms, fatigue, myositis, multimorbidity, morbidity		Rheumatol Int20260
Individual Participant Data Meta-Analysis (IPDMA) of long-term COVID-19 outcomes in a systematic review-informed, international, multidisciplinary database.
PMID 42663308 — quality of life, mortality, stress, physiological, signs and symptoms, covid-19, stress disorders, traumatic, research, infections		Health Soc Care Deliv Res20260
Prognostic Value of the Hata Angiographic Classification for Long-Term Outcomes in Takayasu Arteritis: A Single-Center, Retrospective Study.
PMID 42484113 — takayasu arteritis, retrospective studies, classification, arteritis, cardiology, sex, diagnosis		Arq Bras Cardiol20260
Multicentre international audit of IMACS malignancy screening guidelines in idiopathic inflammatory myopathies: insights from the myositis audit and research collaborative group.
PMID 42457211 — muscular diseases, neoplasms, rheumatic diseases, myositis, research		RMD Open20260
Factors Associated With the High Prevalence of Metabolic Syndrome in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
PMID 42417783 — diabetes mellitus, vasculitis, cardiovascular diseases, cardiology, prevalence, sex, antibodies, antineutrophil cytoplasmic, history, sedentary behavior, metabolic syndrome, granulomatosis with polyangiitis		Arq Bras Cardiol20260

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 8

By phase:

N/A 15
Phase 4 3

By status:

Completed 6
Recruiting 5
Unknown 4
Active not recruiting 2
Terminated 1

By type:

Interventional 16
Observational 2

By Monocentric/Multicentric:

monocentric 17
multicentric2to4 0
multicentric5to9 1
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Therapeutic Strategies for Type 2 Diabetes Based on Lifestyle Changes Plant based Diet and Physical Exercise
NCT06959043 — diabetes mellitus, exercise, insulin resistance, life style, insulin, diet, vegetarian, diet, probiotics, therapeutics, resistance training, gastrointestinal microbiome, metabolic syndrome, diabetes mellitus, type 2, diet, plant-based		N/ARecruiting2022
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
NCT05879419 — dermatomyositis, muscular diseases, cells, sclerosis, glucocorticoids, vasculitis, lipid a, systemic vasculitis, telephone, safety, muscles, vaccines, prednisone, pharmaceutical preparations, spondylitis, ankylosing, liposomes, behcet syndrome, antirheumatic agents, arthritis, immunogenicity, vaccine, ambulatory care facilities, spondylitis, rheumatic diseases, lupus erythematosus, systemic, vaccination, sjogren's syndrome, rituximab, herpes zoster, glycoproteins, myositis, immunity, spondylarthritis, arthritis, rheumatoid, blindness, herpes zoster vaccine, therapeutics, arthritis, juvenile, outpatients, immunosuppression therapy, random allocation, deltoid muscle, scleroderma, systemic, methotrexate, mycophenolic acid, lipids		Phase 4Active not recruiting2023
tDCS in Post Acute COVID 19 Patients With SARDs
NCT04890483 — transcranial direct current stimulation, collagen diseases, motor cortex, collagen, electrodes, rheumatic diseases, signs and symptoms, covid-19, fatigue, autoimmune diseases		N/ARecruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS